REMAP-CAP for COVID 19
- Funded by APPRISE
- Total publications:0 publications
Grant number: unknown
Grant search
Key facts
Disease
COVID-19Start & end year
N/AFunder
APPRISEPrincipal Investigator
Steve Webb, Allen ChengResearch Location
United States of America, Canada…Lead Research Institution
Monash UniversityResearch Priority Alignment
N/A
Research Category
Clinical characterisation and managementResearch Subcategory
Clinical trials for disease managementSpecial Interest Tags
N/AStudy Type
ClinicalClinical Trial Details
UnspecifiedBroad Policy Alignment
PendingAge Group
UnspecifiedVulnerable Population
UnspecifiedOccupations of Interest
Unspecified
Abstract
REMAP-CAP for COVID 19REMAP-CAP is an existing multi-site international adaptive platform trial that was predesigned to adapt in the event of a pandemic.ObjectivesGenerate evidence that can be applied to clinical practice during the pandemic, regarding the impact of multiple candidate interventions to reduce mortality or reduce the length of intensive care unit admission or both in critically ill patients with COVID-19 infection